Security key
126638105
CVRx, Inc. - Common Stock, $0.01 par value (CVRX)
CUSIP: 126638105
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 15,210,504
- Total 13F value
- $108,000,876
- Share change
- +234,253
- SEC-reported price per share
- $7.10
- Number of holders
- 90
- Value change
- +$1,422,903
- Number of buys
- 34
- Number of sells
- 42
- Shares outstanding
- 26,577,273
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
90
Top holders
10
CVRX full security history
Ownership snapshot
Full 13F holder table
CVRx, Inc. SEC filings
CVRx, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JOHNSON & JOHNSON
Disclosed value leader
JOHNSON & JOHNSON
Comparable rows
15/15
Latest evidence
26 Nov 2025
3/4/5
13D/G
13F
Lead comparable stake: 15%
13D/G row: JOHNSON & JOHNSON
Showing 1-6 of 15 holder rows.
Quick read
JOHNSON & JOHNSON leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JOHNSON & JOHNSON's linked filing trail.
Comparable ownership
Top 5
JOHNSON & JOHNSON
15%
NEW ENTERPRISE ASSOCIATES 10 L P
7.8%
Vensana Capital I GP, LLC
7.2%
Gilde Healthcare IV U.a. Cooperat...
4.9%
NEA Management Company, LLC
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON |
3/4/5
13D/G
13F
10%+ Owner · Company
|
15%
from 13D/G
|
$40,369,355
4,024,861 shares
|
-$861,042 | 26 Nov 2025 |
| NEW ENTERPRISE ASSOCIATES 10 L P |
3/4/5
13D/G
10%+ Owner · New Enterprise Associates 10, Limited Partnership
|
7.8%
from 13D/G
|
$37,593,767
2,026,083 shares
|
— | 02 Jul 2021 |
| Vensana Capital I GP, LLC |
13D/G
Kirk Nielsen
|
7.2%
|
$11,849,740
1,760,734 shares
|
$0 | 31 Dec 2024 |
| Gilde Healthcare IV U.a. Cooperatieve |
13D/G
Cooperatieve Gilde Healthcare IV U.A.
|
4.9%
|
$8,287,928
1,231,490 shares
|
$0 | 04 Feb 2025 |
| NEA Management Company, LLC |
13F
Company
|
7.6%
|
$16,350,490
2,026,083 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.1%
|
$8,798,123
1,090,226 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
90
Shares
15,210,504
Rows available
90
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
91
Q4 2025 holders
90
Holder diff
-1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|